Home Cart 0 Sign in  
X

[ CAS No. 31224-43-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 31224-43-8
Chemical Structure| 31224-43-8
Chemical Structure| 31224-43-8
Structure of 31224-43-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 31224-43-8 ]

Related Doc. of [ 31224-43-8 ]

Alternatived Products of [ 31224-43-8 ]

Product Details of [ 31224-43-8 ]

CAS No. :31224-43-8 MDL No. :MFCD07781234
Formula : C6H4FNO Boiling Point : -
Linear Structure Formula :- InChI Key :OZIMPUNGBUYCSP-UHFFFAOYSA-N
M.W : 125.10 Pubchem ID :11344017
Synonyms :
Chemical Name :3-Fluoropicolinaldehyde

Calculated chemistry of [ 31224-43-8 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 29.58
TPSA : 29.96 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.53 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.94
Log Po/w (XLOGP3) : 0.75
Log Po/w (WLOGP) : 1.45
Log Po/w (MLOGP) : 0.22
Log Po/w (SILICOS-IT) : 1.94
Consensus Log Po/w : 1.06

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.52
Solubility : 3.82 mg/ml ; 0.0305 mol/l
Class : Very soluble
Log S (Ali) : -0.96
Solubility : 13.8 mg/ml ; 0.11 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.21
Solubility : 0.773 mg/ml ; 0.00618 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.21

Safety of [ 31224-43-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 31224-43-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 31224-43-8 ]
  • Downstream synthetic route of [ 31224-43-8 ]

[ 31224-43-8 ] Synthesis Path-Upstream   1~18

  • 1
  • [ 31224-43-8 ]
  • [ 272-52-6 ]
YieldReaction ConditionsOperation in experiment
60.4% at 115℃; for 7 h; A mixture of 3-fluoro-2-pyridinecarboxaldehyde (4 g, 32 mmol) and hydrazine (20.5 g) was kept at 115 0C for 7 hr, then cooled to rt. The reaction mixture was diluted with water and extracted with EtOAc. The organic phases were combined, washed with brine, and dried. Concentration followed by flash chromatography afforded 1 H-pyrazolo[4,3-b]pyridine (2.3 g, 60.4percent).
Reference: [1] Patent: WO2008/71451, 2008, A1, . Location in patent: Page/Page column 52
[2] Bioorganic and Medicinal Chemistry, 2004, vol. 12, # 15, p. 4211 - 4219
[3] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 23, p. 6998 - 7003
[4] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 6, p. 1852 - 1856
[5] Patent: WO2011/100607, 2011, A1, . Location in patent: Page/Page column 78
[6] ACS Chemical Neuroscience, 2016, vol. 7, # 9, p. 1192 - 1200
[7] Patent: WO2017/133657, 2017, A1, . Location in patent: Page/Page column 60; 61
[8] Patent: WO2017/133667, 2017, A1, . Location in patent: Page/Page column 172
  • 2
  • [ 372-47-4 ]
  • [ 68-12-2 ]
  • [ 31224-43-8 ]
YieldReaction ConditionsOperation in experiment
60%
Stage #1: With 1,4-diaza-bicyclo[2.2.2]octane; n-butyllithium In diethyl ether; hexane at -70 - -60℃; for 1.5 h;
Stage #2: at -70℃; for 1 h;
To a solution of DABCO (8.8 g, 78.2 mmol) in anhydrous diethyl ether (250 mL) at -25° C. was added n-BuLi (1.6 M in hexanes, 49 mL, 78.2 mmol). The mixture was stirred between -25 to -10° C. for 45 min and then cooled to -70° C. To the above solution was added 3-fluoropyridine (5.9 mL, 71 mmol) dropwise. The reaction was stirred between -70 to -60° C. for 1.5 h before DMF (11.0 mL, 2.0 eq.) was added. After 1.0 h stirring at -70° C., water (150 mL) was added and warmed up to rt. The layers were separated and the aqueous layer was extracted with methylene chloride (5.x.100 mL). The combined organic layer was washed with brine and dried over Na2SO4. After removal of solvent, the crude was purified by silica gel column chromatography using gradient EtOAc in hexanes to give 5.4 g (55-60percent yield) of 65A. 1H NMR (400 MHz, CDCl3) δ ppm 7.54-7.57 (m, 2H) 8.61 (d, J=2.20 Hz, 1H) 10.20 (s, 1H).
43%
Stage #1: With n-butyllithium; N,N,N,N,-tetramethylethylenediamine In diethyl ether; hexane at -78 - -20℃; for 2.41667 h;
Stage #2: at -78℃; for 2.16667 h;
n-Butyllithium (2.0 M in hexanes, 27.5 ml, 55 mmol) was added dropwise over 10 minutes at -200C to a solution of Λ/,Λ/,Λ/',Λ/'-tetramethylethylenediamine (7.5 ml, 50 mmol) in anhydrous diethyl ether (200 ml). The reaction mixture was stirred at -200C for 1 hour, then it was cooled to -78°C and 3- fluoropyridine (4.3 ml, 50 mmol), in diethyl ether (10 ml), was added dropwise over 15 minutes at - 78°C. The reaction mixture was stirred at" ι-78°C for 1 hour, after which time N1N- Dimethylformamide (4.3 ml, 55 mmol), in diethyl ether (10 ml), was added dropwise over 10 minutes at -78°C. It was stirred for 2 hours, then poured carefully onto a rapidly stirring ice/water mixture (300 ml). The mixture was stirred for 20 minutes, then diluted with ethyl acetate (200 ml). The layers were separated and the aqueous layer was further extracted with dichloromethane (4 x 50 ml). The organic solutions were combined and concentrated under reduced pressure, and the resulting crude product was purified by column chromatography on silica gel using EPO <DP n="49"/>dichloromethane:pentane as eluant (0:100 to 60:40 v/v) to yield the title compound (2.7 g, 43percent) as a solid.1H NMR (400MHz, CDCI3): δ 7.56-7.60 (m, 2H)1 8.63 (m, 1 H), 10.22 (s, 1 H).
Reference: [1] Patent: US2010/227894, 2010, A1, . Location in patent: Page/Page column 55
[2] Patent: WO2006/114706, 2006, A1, . Location in patent: Page/Page column 47-48
[3] Tetrahedron, 1983, vol. 39, # 12, p. 2009 - 2021
[4] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 23, p. 6998 - 7003
[5] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 6, p. 1852 - 1856
[6] Patent: WO2012/177896, 2012, A1, . Location in patent: Page/Page column 89-90
[7] Organic Process Research and Development, 2007, vol. 11, # 4, p. 716 - 720
  • 3
  • [ 372-47-4 ]
  • [ 60-29-7 ]
  • [ 31224-43-8 ]
Reference: [1] Patent: WO2012/177893, 2012, A2, . Location in patent: Page/Page column 102-103
  • 4
  • [ 68-12-2 ]
  • [ 31224-43-8 ]
YieldReaction ConditionsOperation in experiment
11%
Stage #1: With 1,4-diaza-bicyclo[2.2.2]octane; n-butyllithium In diethyl ether; hexane at -78 - -20℃; for 2 h;
Stage #2: at -60 - -20℃; for 4 h;
ra-Butyl lithium (1.6 M in hexanes, 6.86 mL, 11.0 mmol) was added to a stirred solution of 1,4- diazobicyclo[2.2.2]-octane (1.23 g, 11.0 mmol) in dry Et2O (55 mL) at -780C under N2. The reaction was warmed to -200C and stirred for 1 h. The reaction was cooled to -78 0C and a solution of 3- fluoropyridine (1.07 g, 11.0 mmol) in Et2ψ (5.5 mL) was added dropwise via cannula. The reaction was warmed to -600C and stirred for 1 h after which time a yellow precipitate appeared. DMF (803 mg, 847 μL, 12.1 mmol) was added dropwise and the reaction was gradually warmed to -20 0C over 4 h. Water (20 mL) was added and the mixture was extracted with Et2O (3 x 40 mL). The combined extracts were dried (Na2SO4) and concentrated in vacuo to give the crude product. This was purified by flash chromatography (Si, 25 x 160 mm, 0-60percent EtOAc in hexanes gradient) to afford 3-fluoropyridine-2- carbaldehyde (152.3 mg, 11percent). Ry= 0.23 (20percent EtOAc/hexanes). LCMS calc. = 126.0; found = 125.9 (M+l)+. 1H NMR (500 MHz, CDCl3): δ 10.14 (d, J = 2.4 Hz, 1 H); 8.57 (m, 1 H); 7.57-7.53 (m, 2 H).
Reference: [1] Patent: WO2007/81571, 2007, A2, . Location in patent: Page/Page column 72
  • 5
  • [ 372-47-4 ]
  • [ 31224-43-8 ]
Reference: [1] Patent: WO2005/12306, 2005, A2, . Location in patent: Page/Page column 49
  • 6
  • [ 372-47-4 ]
  • [ 31224-43-8 ]
YieldReaction ConditionsOperation in experiment
35% With n-butyllithium In diethyl ether; hexane; water; N,N-dimethyl-formamide 2-Formyl-3-fluoropyridine
Dry ethyl ether (500 mL), n-BuLi (1.6M in hexane, 62.5 mL, 0.1 mol), and dry 1,4-diazabicyclo[2.2.2]octane (DABCO) (11.56 g, 0.1 mol) were introduced into a 1 L flask under a dry N2 stream at -60° C. and the resulting cloudy solution was stirred for 1 hour at -20° C.
The mixture was then cooled to -75° C. and an ethyl ether (50 mL) solution of 3-fluoropyridine (9.81 g, 0.1 mol) was added dropwise and stirring continued for 11/2 hours at -60° C.
The mixture was recooled to -75° C., dry N,N-dimethylformamide (8.52 mL, 0.11 mol) dissolved in ethyl ether (50 mL) was added dropwise and the mixture stirred for 2 hours at -75° C. Water (175 mL) was introduced slowly at -10° C., the aqueous layer extracted with ethyl acetate (5*200 mL), and the combined extracts were dried over anhydrous sodium sulfate.
Solvent removal produced a dark brown oil which after vacuum distillation and purification by chromatography on silica gel provided 4.4 g (35percent) of the titled product as an off-white crystalline solid:
mp 48°-49° C.;
IR (CHCl3, cm-1) 3071, 3020, 2873, 2842, 1720, 1588, 1461, 1441;
1 H NMR (300 MHz, CDCl3) δ10.21 (s, 1H), 8.62 (m, 1H), 7.57 (m, 2H);
MS (FD) m/e 125 (M+);
Reference: [1] Patent: US5593993, 1997, A,
  • 7
  • [ 372-47-4 ]
  • [ 31224-43-8 ]
Reference: [1] Patent: US5716971, 1998, A,
  • 8
  • [ 1319649-53-0 ]
  • [ 31224-43-8 ]
Reference: [1] Journal of Fluorine Chemistry, 2011, vol. 132, # 8, p. 541 - 547
  • 9
  • [ 1824-81-3 ]
  • [ 31224-43-8 ]
Reference: [1] Journal of Fluorine Chemistry, 2011, vol. 132, # 8, p. 541 - 547
  • 10
  • [ 3430-10-2 ]
  • [ 31224-43-8 ]
Reference: [1] Journal of Fluorine Chemistry, 2011, vol. 132, # 8, p. 541 - 547
  • 11
  • [ 22280-60-0 ]
  • [ 31224-43-8 ]
Reference: [1] Journal of Fluorine Chemistry, 2011, vol. 132, # 8, p. 541 - 547
  • 12
  • [ 28489-45-4 ]
  • [ 31224-43-8 ]
Reference: [1] Journal of Fluorine Chemistry, 2011, vol. 132, # 8, p. 541 - 547
  • 13
  • [ 22280-62-2 ]
  • [ 31224-43-8 ]
Reference: [1] Journal of Fluorine Chemistry, 2011, vol. 132, # 8, p. 541 - 547
  • 14
  • [ 372-47-4 ]
  • [ 109-94-4 ]
  • [ 31224-43-8 ]
Reference: [1] Tetrahedron, 1983, vol. 39, # 12, p. 2009 - 2021
  • 15
  • [ 31224-43-8 ]
  • [ 31181-79-0 ]
YieldReaction ConditionsOperation in experiment
93% With sodium borohydrid In ethanol; ethyl acetate 2-Hydroxymethyl-3-fluoropyridine
A solution of 2-formyl-3-fluoropyridine (4.0 g, 32 mmol) and sodium borohydride (309 mg, 8 mmol) in absolute ethanol (40 mL) was stirred at 0° C. for 15 minutes and at room temperature for 1 hour.
The reaction was quenched with saturated aqueous ammonium chloride (5 mL) and filtered through diatomaceous earth to remove solids.
The filtrate was evaporated and the resultant white solid was dissolved in ethyl acetate and water.
The aqueous layer was extracted with ethyl acetate (5*30 mL) and the combined extracts were dried over anhydrous sodium sulfate.
Solvent removal provided 3.78 g (93percent) of the titled product as a pale yellow oil:
IR (CHCl3, cm-1) 3607, 3439, 3019, 1607, 1576, 1451, 1416, 1312, 1257, 1218, 1209, 1167, 1105, 1053, 857, 803;
1 H NMR (300 MHz, CDCl3) δ8.38 (m, 1H), 7.39 (m, 1H), 7.26 (m, 1H), 4.83 (s, 2H), 3.73 (br s, 1H);
MS (FD) m/e 127 (M+);
Reference: [1] Patent: US5593993, 1997, A,
  • 16
  • [ 31224-43-8 ]
  • [ 124-41-4 ]
  • [ 51984-46-4 ]
YieldReaction ConditionsOperation in experiment
45%
Stage #1: at 80℃; for 4 h;
Stage #2: With sodium tetrahydroborate In methanol at 0℃; for 0.333333 h;
To a flask charged with 3-fluoropicolinaldehyde (400 mg, 3.20 mmol) was added sodium methoxide (15 mL, 7.50 mmol) (0.5M in MeOH ). The mixture was stirred at 80 0C for 4h. The reaction mixture was then cooled to 00C with an ice bath and NaBH4 (90 mg, 2.38 mmol) was added to the mixture was stirred at 00C for 20 min before ice was added to the mixture. After concentration in vacuo, the residue was purified with ISCO MPLC (40- 100percent EtOAc/hexane) to yield the title compound as a white solid (200 mg, 45.0 percent). 1H NMR (DMSO-de) δ 8.11 (dd, 1 H), 7.41 (dd, 1 H), 7.31 (dd, 1 H), 4.83 (t, 1 H), 4.54 (d, 2 H), 3.82 (s, 3 H). MS (M+H+) = 140.
Reference: [1] Patent: WO2009/27746, 2009, A1, . Location in patent: Page/Page column 115
  • 17
  • [ 31224-43-8 ]
  • [ 633328-33-3 ]
Reference: [1] Patent: WO2011/100607, 2011, A1,
[2] ACS Chemical Neuroscience, 2016, vol. 7, # 9, p. 1192 - 1200
  • 18
  • [ 31224-43-8 ]
  • [ 1330624-42-4 ]
Reference: [1] ACS Chemical Neuroscience, 2016, vol. 7, # 9, p. 1192 - 1200
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 31224-43-8 ]

Fluorinated Building Blocks

Chemical Structure| 87674-20-2

[ 87674-20-2 ]

2-Acetyl-3-fluoropyridine

Similarity: 0.88

Chemical Structure| 15931-15-4

[ 15931-15-4 ]

3-Fluoro-2-methylpyridine

Similarity: 0.84

Chemical Structure| 669066-93-7

[ 669066-93-7 ]

5-Bromo-3-fluoropyridine-2-carboxaldehyde

Similarity: 0.83

Chemical Structure| 884494-77-3

[ 884494-77-3 ]

6-Chloro-3-fluoropicolinaldehyde

Similarity: 0.82

Chemical Structure| 1227499-98-0

[ 1227499-98-0 ]

3-Fluoro-5-(trifluoromethyl)picolinaldehyde

Similarity: 0.79

Aldehydes

Chemical Structure| 669066-93-7

[ 669066-93-7 ]

5-Bromo-3-fluoropyridine-2-carboxaldehyde

Similarity: 0.83

Chemical Structure| 884494-77-3

[ 884494-77-3 ]

6-Chloro-3-fluoropicolinaldehyde

Similarity: 0.82

Chemical Structure| 1227499-98-0

[ 1227499-98-0 ]

3-Fluoro-5-(trifluoromethyl)picolinaldehyde

Similarity: 0.79

Chemical Structure| 31181-88-1

[ 31181-88-1 ]

5-Fluoropicolinaldehyde

Similarity: 0.73

Chemical Structure| 1121-60-4

[ 1121-60-4 ]

2-Pyridinecarboxaldehyde

Similarity: 0.72

Related Parent Nucleus of
[ 31224-43-8 ]

Pyridines

Chemical Structure| 87674-20-2

[ 87674-20-2 ]

2-Acetyl-3-fluoropyridine

Similarity: 0.88

Chemical Structure| 15931-15-4

[ 15931-15-4 ]

3-Fluoro-2-methylpyridine

Similarity: 0.84

Chemical Structure| 669066-93-7

[ 669066-93-7 ]

5-Bromo-3-fluoropyridine-2-carboxaldehyde

Similarity: 0.83

Chemical Structure| 884494-77-3

[ 884494-77-3 ]

6-Chloro-3-fluoropicolinaldehyde

Similarity: 0.82

Chemical Structure| 1227499-98-0

[ 1227499-98-0 ]

3-Fluoro-5-(trifluoromethyl)picolinaldehyde

Similarity: 0.79